Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Licensing opportunity from NIH: novel antitumor macrocyclic lactones

July 9, 2001

Steroid sulfatase inhibitors in development by Novartis for cancer, etc.

July 6, 2001

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

July 6, 2001

WHI-P154 claimed for sensitizing cancer cells to radiation

July 6, 2001

Several series of antineoplastic agents presented by ADIR in patents

July 6, 2001

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

July 6, 2001

Wyeth-Ayerst and Taxolog to develop novel taxanes

July 6, 2001

Peregrine's TNT treatment shows positive results in phase I/II trial

July 5, 2001

Bradykinin B2 antagonists with anticancer activity

July 5, 2001

AEterna's Neovastat demonstrates safety and dose-related activity in prostate cancer trial

July 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...